Cargando…

(18)F-fluorothymidine (FLT)-PET and diffusion-weighted MRI for early response evaluation in patients with small cell lung cancer: a pilot study

BACKGROUND: Small cell lung cancer (SCLC) is an aggressive cancer often presenting in an advanced stage and prognosis is poor. Early response evaluation may have impact on the treatment strategy. AIM: We evaluated (18)F-fluorothymidine-(FLT)-PET/diffusion-weighted-(DW)-MRI early after treatment star...

Descripción completa

Detalles Bibliográficos
Autores principales:	Christensen, Tine Nøhr, Langer, Seppo W., Villumsen, Katrine Engholm, Johannesen, Helle Hjorth, Löfgren, Johan, Keller, Sune Høgild, Hansen, Adam Espe, Kjaer, Andreas, Fischer, Barbara Malene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218141/ https://www.ncbi.nlm.nih.gov/pubmed/34191195 http://dx.doi.org/10.1186/s41824-019-0071-5

Ejemplares similares

Impact of [(18)F]FDG-PET and [(18)F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer
por: Christensen, Tine N., et al.
Publicado: (2021)

Correction: Christensen et al. Impact of [(18)F]FDG-PET and [(18)F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer. Diagnostics 2021, 11, 279
por: Christensen, Tine N., et al.
Publicado: (2022)

Very Early Response Evaluation by PET/MR in Patients with Lung Cancer—Timing and Feasibility
por: Langer, Natasha Hemicke, et al.
Publicado: (2019)

Prognostic Value of (18)F–FDG–PET Parameters in Patients with Small Cell Lung Cancer: A Meta-Analysis and Review of Current Literature
por: Christensen, Tine Nøhr, et al.
Publicado: (2021)

Impact of incorrect tissue classification in Dixon-based MR-AC: fat-water tissue inversion
por: Ladefoged, Claes Nøhr, et al.
Publicado: (2014)

(64)Cu-DOTATATE PET/MRI for Detection of Activated Macrophages in Carotid Atherosclerotic Plaques: Studies in Patients Undergoing Endarterectomy
por: Pedersen, Sune Folke, et al.
Publicado: (2015)

(18)F-fluorothymidine PET imaging in gliomas: an update
por: Nikaki, Alexandra, et al.
Publicado: (2017)

Initial Experience with (64)Cu-DOTATATE Digital PET of Patients with Neuroendocrine Neoplasms: Comparison with Analog PET
por: Loft, Mathias, et al.
Publicado: (2021)

Evaluation of the Performance of 18F-Fluorothymidine Positron Emission Tomography/Computed Tomography (18F-FLT-PET/CT) in Metastatic Brain Lesions
por: Nikaki, Alexandra, et al.
Publicado: (2019)

Diagnostic value of PET/CT with (11)C-methionine (MET) and (18)F-fluorothymidine (FLT) in newly diagnosed glioma based on the 2016 WHO classification
por: Ogawa, Tomoya, et al.
Publicado: (2020)

Early Response Assessment to Targeted Therapy Using 3′-deoxy-3′[(18)F]-Fluorothymidine ((18)F-FLT) PET/CT in Lung Cancer
por: Kairemo, Kalevi, et al.
Publicado: (2020)

Calcium electroporation for recurrent head and neck cancer: A clinical phase I study
por: Plaschke, Christina Caroline, et al.
Publicado: (2019)

PET/MR imaging of sarcomas: effect of PET quantification by classification of tissue
por: Ladefoged, Claes Nøhr, et al.
Publicado: (2014)

Toxicology evaluation of radiotracer doses of 3'-deoxy-3'-[(18)F]fluorothymidine ((18)F-FLT) for human PET imaging: Laboratory analysis of serial blood samples and comparison to previously investigated therapeutic FLT doses
por: Turcotte, Eric, et al.
Publicado: (2007)

Evaluation of (18)F-fluorothymidine positron emission tomography ([(18)F]FLT-PET/CT) methodology in assessing early response to chemotherapy in patients with gastro-oesophageal cancer
por: Sharma, R., et al.
Publicado: (2016)

Molecular Imaging with 3′-deoxy-3′[(18)F]-Fluorothymidine ((18)F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot Study
por: Kairemo, Kalevi, et al.
Publicado: (2020)

(18)F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancer
por: Wieder, Hinrich, et al.
Publicado: (2018)

(18)F-fluorodeoxyglucose (FDG) PET or (18)F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study
por: Romine, Perrin E., et al.
Publicado: (2021)

Preliminary (19)F-MRS Study of Tumor Cell Proliferation with 3′-deoxy-3′-fluorothymidine and Its Metabolite (FLT-MP)
por: Ko, In Ok, et al.
Publicado: (2017)

Identification and characterization of human brown adipose tissue (BAT) content and metabolism in adults using [(18)F]-FDG PET/MR – a pilot study
por: Johannesen, Helle H, et al.
Publicado: (2014)

Monitoring Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using (18)F-Fluorothymidine PET
por: Sharma, Rohini, et al.
Publicado: (2020)

In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET
por: Wong, Peter K., et al.
Publicado: (2014)

Early reduction in tumour [(18)F]fluorothymidine (FLT) uptake in patients with non-small cell lung cancer (NSCLC) treated with radiotherapy alone
por: Trigonis, Ioannis, et al.
Publicado: (2014)

Comparison of 4′-[methyl-(11)C]thiothymidine ((11)C-4DST) and 3′-deoxy-3′-[(18)F]fluorothymidine ((18)F-FLT) PET/CT in human brain glioma imaging
por: Toyota, Yasunori, et al.
Publicado: (2015)

Exploratory Analysis of (18)F-3’-deoxy-3’-fluorothymidine ((18)F-FLT) PET/CT-Based Radiomics for the Early Evaluation of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer
por: Fantini, Lorenzo, et al.
Publicado: (2021)

Synthesis and evaluation of 3′-[(18)F]fluorothymidine-5′-squaryl as a bioisostere of 3′-[(18)F]fluorothymidine-5′-monophosphate
por: Brickute, D., et al.
Publicado: (2021)

[(18)F]Fluorothymidine PET imaging in the diagnosis of leptomeningeal involvement with diffuse large B-cell lymphoma
por: Holter, Jennifer L., et al.
Publicado: (2011)

Evaluation of limited blood sampling population input approaches for kinetic quantification of [(18)F]fluorothymidine PET data
por: Contractor, Kaiyumars B, et al.
Publicado: (2012)

An Assessment of Early Response to Targeted Therapy via Molecular Imaging: A Pilot Study of 3′-deoxy-3′[(18)F]-Fluorothymidine Positron Emission Tomography (18)F-FLT PET/CT in Prostate Adenocarcinoma
por: Kairemo, Kalevi, et al.
Publicado: (2017)

Eosinophilic Cystitis Presenting as Possible Pediatric Rhabdomyosarcoma in Conventional Imaging Including (18)F-FDG-PET/CT/MRI—A Rare Case
por: Enevold Olsen, Naja, et al.
Publicado: (2021)

CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab
por: Skougaard, Kristin, et al.
Publicado: (2014)

(18)F-Fluorothymidine-Pet Imaging of Glioblastoma Multiforme: Effects of Radiation Therapy on Radiotracer Uptake and Molecular Biomarker Patterns
por: Chandrasekaran, Sanjay, et al.
Publicado: (2013)

Visual stimuli induce serotonin release in occipital cortex: A simultaneous positron emission tomography/magnetic resonance imaging study
por: Hansen, Hanne Demant, et al.
Publicado: (2020)

Multi-parametric PET/MRI for enhanced tumor characterization of patients with cervical cancer
por: Ahangari, Sahar, et al.
Publicado: (2022)

Cross calibration of the Siemens mMR: easily acquired accurate PET phantom measurements, long term stability and reproducibility
por: Keller, Sune H, et al.
Publicado: (2015)

Pilot study assessing (18)F-fluorothymidine PET/CT in cervical and vaginal cancers before and after external beam radiation()
por: Cho, Linda P., et al.
Publicado: (2015)

Voxel-Based Analysis of the Relation of 3′-Deoxy-3′-[(18)F]fluorothymidine ([(18)F]FLT) PET and Diffusion-Weighted (DW) MR Signals in Subcutaneous Tumor Xenografts Does Not Reveal a Direct Spatial Relation of These Two Parameters
por: Schelhaas, Sonja, et al.
Publicado: (2021)

Development of a Symmetric Echo-Planar Spectroscopy Imaging Framework for Hyperpolarized (13)C Imaging in a Clinical PET/MR Scanner
por: Eldirdiri, Abubakr, et al.
Publicado: (2018)

Diagnostic Value of (11)C-Methionine (MET) and (18)F-Fluorothymidine (FLT) Positron Emission Tomography in Recurrent High-Grade Gliomas; Differentiation from Treatment-Induced Tissue Necrosis
por: Shishido, Hajime, et al.
Publicado: (2012)

The Positron Emission Tomography Tracer 3’-Deoxy-3’-[(18)F]Fluorothymidine ([(18)F]FLT) Is Not Suitable to Detect Tissue Proliferation Induced by Systemic Yersinia enterocolitica Infection in Mice
por: Wiehr, Stefan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0ikleck7mo269smtsbcdml11lf